The Society of Interventional Radiology (SIR) has published new practice guidance for the use of prostatic artery ...

The Society of Interventional Radiology (SIR) published a new practice guidance on prostate artery embolization (PAE) for the ...

Please provide your email address to receive an email when new articles are posted on . Benign prostatic hyperplasia is the most common benign tumor found in men. Prostate artery embolization is ...

For men with benign prostatic hyperplasia (BPH), prostatic artery embolization (PAE) is safe and effective over 24 months of follow-up, according to a study published online Sept. 4 in Cardiovascular ...

The Society of Interventional Radiology (SIR) published new practice guidance for the use of prostatic artery embolization (PAE) to treat enlarged prostate (also called benign prostatic hyperplasia or ...

Investigators compared prostatic artery embolization against a combination of an alpha blocker and 5-alpha reductase inhibitor for BPH. Prostatic artery embolization (PAE) yields greater clinical ...

PAE is safe and effective for men with lower urinary tract symptoms or acute urinary retention. (HealthDay News) — For men with benign prostatic hyperplasia (BPH), prostatic artery embolization (PAE) ...

MINNEAPOLIS--(BUSINESS WIRE)--In 2012, Dr. Jafar Golzarian performed the first prostate artery embolization (PAE) in the U.S. Today, he is confidently performing PAE on an outpatient basis at North ...

Men suffering from an enlarged prostate can receive long-term relief from a minimally invasive procedure that partially blocks blood flow to the gland, new research reports. The procedure, called ...

Prostate artery embolization (PAE) is a procedure that helps treat urinary symptoms of an enlarged prostate without a risk of sexual side effects. Typically, both Original Medicare (parts A and B) and ...

FAIRFAX, Va. (March 1, 2023)—Prostate artery embolization (PAE) provides long-term effectiveness in treating urinary symptoms from an enlarged prostate gland, according to new research to be presented ...